Resonac core operating profit more than doubles to ¥88.8 billion in FY26 1H; revenue rises 5% to ¥676.9 billion
Reuters2026/08/06 06:43- Resonac posted 2026 first-half revenue of ¥676.9 billion, up 5%, while core operating profit more than doubled to ¥88.8 billion.
- Profit attributable to owners climbed to ¥48.5 billion, up 147%, while IFRS operating profit rose to ¥73.3 billion from ¥32.6 billion.
- EBITDA margin improved to 19.8% from 12.8%, while adjusted net D/E ratio fell to 0.65 from 0.83 at June 30.
- Semiconductor and Electronic Materials revenue rose 30% to ¥299.0 billion, lifting core operating profit 92% to ¥81.5 billion, a quarterly record.
- Full-year forecast lifted to ¥196.0 billion in core operating profit from ¥140.0 billion, with EBITDA margin seen at 24.4% from 17.9%.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Most panda coin types from the 2026 edition steadily rebounded in August
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage
Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

2-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - U.S. vs Other Nations